aTYR PHARMA (ATYR) Price to Book (2015 - 2026)
aTYR PHARMA's (ATYR) quarterly Price to Book came in at 1.21 in Q2 2026, down 80.87% on a YoY basis from 6.31 in Q2 2025, and down 8.93% quarter-over-quarter from 1.32 in Q1 2026.
Powered by 
Analysis
aTYR PHARMA (ATYR) Price to Book (2015 - 2026) Analysis & Trends
aTYR PHARMA (ATYR) has reported Price to Book for 12 consecutive years, with 1.21 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Book fell 80.87% year-over-year to 1.21; the trailing twelve-month figure through Jun 2026 stood at 1.21 (down 80.87% YoY), and the FY2025 full-year result was 1.14, down 73.89% from the prior year.
- Price to Book eased to 1.21 in Q2 2026 per ATYR's latest filing, from 1.32 in the prior quarter.
- Across five years, Price to Book topped out at 6.31 in Q2 2025 and bottomed at 0.8 in Q1 2023.
- Historically, Price to Book has averaged 1.79 across 5 years, with a median of 1.18 in 2026.
- The sharpest annual moves came in 2024 and 2026: Price to Book jumped 341.68% in 2024, then plunged 80.87% in 2026.
- Over 5 years, Price to Book stood at 0.91 in 2022, then climbed by 8.84% to 0.99 in 2023, then surged by 341.68% to 4.36 in 2024, then plunged by 73.89% to 1.14 in 2025, then climbed by 6.03% to 1.21 in 2026.
- According to Business Quant data, Price to Book over the past three periods registered 1.21, 1.32, and 1.14 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 |
| Mar 31, 2026 | 1.32 |
| Dec 31, 2025 | 1.14 |
| Sep 30, 2025 | 0.88 |
| Jun 30, 2025 | 6.31 |
| Mar 31, 2025 | 3.59 |
| Dec 31, 2024 | 4.36 |
| Sep 30, 2024 | 2.05 |
| Jun 30, 2024 | 1.45 |
| Mar 31, 2024 | 1.58 |
| Dec 31, 2023 | 0.99 |
| Sep 30, 2023 | 0.94 |
| Jun 30, 2023 | 1.16 |
| Mar 31, 2023 | 0.80 |
| Dec 31, 2022 | 0.91 |
| Sep 30, 2022 | 1.13 |
| Jun 30, 2022 | 0.92 |
| Mar 31, 2022 | 1.53 |
| Dec 31, 2021 | 1.31 |
| Sep 30, 2021 | 1.40 |